Women with epilepsy: Clinically relevant issues

Functional Neurology

Volumn 31, Issue 3, 2016, Pages 127-134

  Bangar, Santosh ^a   Shastri, Abhishek ^b   El Sayeh, Hany ^c   Cavanna, Andrea E ^d,e,f  

^a LEEDS AND YORK PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^b DORSET HEALTHCARE UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c The Royal College of Psychiatrists   (United Kingdom)

^d BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^e ASTON UNIVERSITY   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiepileptic drugs; Contraception; Epilepsy; Gender; Pregnancy; Seizures; Women

Indexed keywords

ACETAZOLAMIDE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; CLOBAZAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ANTICONVULSIVE AGENT;

CONTRACEPTIVE BEHAVIOR; EPILEPSY; HUMAN; INFERTILITY THERAPY; KNOWLEDGE; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; MENTAL HEALTH; PROBABILITY; REVIEW; SEIZURE; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE; TONIC CLONIC SEIZURE; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMPLICATION; CONTRACEPTION; DRUG EFFECTS; FEMALE; LACTATION; PREGNANCY; PREGNANCY COMPLICATION; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; WOMEN'S HEALTH;

ANTICONVULSANTS; CONTRACEPTION; EPILEPSY; FEMALE; HUMANS; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; WOMEN'S HEALTH;

EID: 84989193337     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: 10.11138/FNeur/2016.31.3.127     Document Type: Review

References (77)

1. Beghi E, Roncolato M, Visoná G (2004). Depression and altered quality of life in women with epilepsy of childbearing age. Epilepsia 45:64-70.
2. Berg AT, Berkovic SF, Brodie MJ, et al (2010). Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51:676-685.
3. Bjørk M, Veiby G, Engelsen B, Gilhus NE (2015). Depression and anxiety during pregnancy and the postpartum period in women with epilepsy: a review of frequency, risks and recommendations for treatment. Seizure 28:39-45.
4. Bromley R, Weston J, Adab N, et al (2014). Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev (10):CD010236.
5. Cavanna AE, Ali F, Rickards HE, et al (2010). Behavioral and cognitive effects of anti-epileptic drugs. Discov Med 9:138-144.
6. Cavanna AE, Cavanna S, Bertero L, et al (2009). Depression in women with epilepsy: Clinical and neurobiological aspects. Funct Neurol 24:83-87.
7. Christensen J, Grønborg TK, Sørensen MJ, et al (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309:1696-1703.
8. Crawford P (2005). Best practice guidelines for the management of women with epilepsy. Epilepsia 46(Suppl 9):117-124.
9. de Leon J (2004). Psychopharmacology: atypical antipsychotic dosing: the effect of co-medication with anticonvulsants. Psychiatr Serv 55:125-128.
10. Dutton C, Foldvary-Schaefer N (2008). Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management. Int Rev Neurobiol 83:113-134.
11. Eddy CM, Rickards H, Cavanna AE (2012). Behavioral adverse effects of antiepileptic drugs in epilepsy. J Clin Psychopharmacol 32:362-375.
12. EURAP Study Group (2006). Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 66:354-360.
13. Farooq S, Sherin A (2008). Interventions for psychotic symptoms concomitant with epilepsy. Cochrane Database Syst Rev (4):CD006118.
14. Feely M, Gibson J (1984). Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 47:1279-1282.
15. Fisher RS, Acevedo C, Arzimanoglou A, et al (2014). ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475-482.
16. Foldvary-Schaefer N, Falcone T (2003). Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 61 (Suppl 2):S2-15.
17. French JA (2013). Treatment of catamenial epilepsy is still up in the air. Epilepsy Curr 13:71-72.
18. Gaffield ME, Culwell KR, Lee CR (2011). The use of hormonal contraception among women taking anticonvulsant therapy. Contraception 83:16-29.
19. Galanti M, Newport DJ, Pennell PB, et al (2009). Postpartum depression in women with epilepsy: Influence of antiepileptic drugs in a prospective study. Epilepsy Behav 16:426-430.
20. Galbally M, Snellen M, Lewis AJ (2011). A review of the use of psychotropic medication in pregnancy. Curr Opin Obstet Gynecol 23:408-414.
21. Gidal BE, French JA, Grossman P, et al (2009). Assessment of potential drug interactions in patients with epilepsy: impact of age and sex. Neurology 72:419-425.
22. Gil-Nagel A, López-Muñoz F, Serratosa JM (2006). Effect of lamotrigine on sexual function in patients with epilepsy. Seizure 15:142-149.
23. Harden CL, Pennell PB (2013). Neuroendocrine considerations in the treatment of men and women with epilepsy. Lancet Neurol 12:72-83.
24. Harden CL, Meador KJ, Pennell PB, et al (2009a). Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73:133-141.
25. Harden CL, Pennell PB, Koppel BS, et al (2009b). Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50:1247-1255.
26. Harden CL (2008). Sexual dysfunction in women with epilepsy. Seizure 17:131-135.
27. Harden CL, Pulver MC, Ravdin L, et al (1999). The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 40:1402-1407.
28. Heo K, Rhee Y, Lee HW, et al (2011). The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Epilepsia 52:1884-1889.
29. Herzog AG, Fowler KM, Smithson SD, et al (2012). Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial. Neurology 78:1959-1966.
30. Herzog AG, Fowler KM, Sperling MR, et al (2011). Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia 52:1843-1848.
31. Herzog AG (2006). Menstrual disorders in women with epilepsy. Neurology 66 (Suppl 3):S23-28.
32. Herzog AG, Klein P, Ransil BJ (1997). Three patterns of catamenial epilepsy. Epilepsia 38:1082-1088.
33. Hu X, Wang J, Dong W, et al (2011). A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Res 97:73-82.
34. Jackson M (2006). Epilepsy in women: A practical guide to management. Practical Neurology 6:166-179.
35. Johnston CA, Crawford PM (2014). Anti-epileptic drugs and hormonal treatments. Curr Treat Options Neurol 16:288.
36. Jones I, Chandra PS, Dazzan P, et al (2014). Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet 384:1789-1799.
37. Jones R, Rickards H, Cavanna AE (2010). The prevalence of psychiatric disorders in epilepsy: a critical review of the evidence. Funct Neurol 25:191-194.
38. Kanner AM (2008). The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol 28:379-388.
39. Karouni M, Arulthas S, Larsson PG, et al (2010). Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 66:1151-1160.
40. Karouni M, Henning O, Larsson PG, et al (2013). Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy. Epilepsy Behav 29:77-81.
41. Kerr MP, Mensah S, Besag F, et al (2011). International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 52:2133-2138.
42. Kim GH, Lee HW, Park H, et al (2010). Seizure exacerbation and hormonal cycles in women with epilepsy. Epilepsy Res 90:214-220.
43. Komolafe MA, Sunmonu TA, Afolabi OT, et al (2012). The social and economic impacts of epilepsy on women in Nigeria. Epilepsy Behav 24:97-101.
44. Isojärvi JI, Taubøll E, Herzog AG (2005). Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 19:207-223.
45. Lee KC, Finley PR, Alldredge BK (2003). Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf 2:233-247.
46. Lobo RA (1995). A disorder without identity: “HCA”, “PCO”, “PCOD”, “PCOS”, “SLS”. What are we to call it?! Fertil Steril 63:1158-1160.
47. Maguire MJ, Weston J, Singh J, et al (2014). Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev (12):CD010682.
48. Malkan A, Beran RG (2014). An appraisal of the new operational definition of epilepsy-then and now. Epilepsy Behav 41:217-220.
49. Meador KJ, Baker GA, Browning N, et al (2009). Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:1597-1605.
50. Mikkonen K, Vainionpää, LK, Pakarinen AJ, et al (2004). Longterm reproductive endocrine health in young women with epilepsy during puberty. Neurology 62:445-450.
51. Morrell MJ, Hayes FJ, Sluss PM, et al (2008). Hyperandro-genism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. Ann Neurol 64:200-211.
52. Morrell MJ (1999). Epilepsy in women: the science of why it is special. Neurology 53(Suppl 1):S42-48.
53. Mula M (2008). Anticonvulsants-antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology. Curr Drug Metab 9:730-737.
54. National Institute for Health and Care Excellence (2012). The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. CG137. London, National Institute for Health and Care Excellence.
55. Nei M, Daly S, Liporace J (1998). A maternal partial complex seizure in labor can affect fetal heart rate. Neurology 51:904-906.
56. O’Brien MD, Guillebaud J (2010). Contraception for women taking antiepileptic drugs. J Fam Plann Reprod Health Care 36:239-242.
57. Okazaki M, Adachi N, Akanuma N, et al (2014). Do antipsychotic drugs increase seizure frequency in epilepsy patients? Eur Neuropsychopharmacol 24:1738-1744.
58. Ozkara C, Ozdemir S, Yilmaz A, et al (2006). Orgasm-induced seizures: a study of six patients. Epilepsia 47:2193-2197.
59. Pack AM, Morrell MJ, Randall A, et al (2008). Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 70: 1586-1593.
60. Pearlman MD, Tintinalli JE, Lorenz RP (1990). Blunt trauma during pregnancy. N Engl J Med 323:1609-1613.
61. Piedad J, Rickards H, Besag FM, et al (2012). Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations. CNS Drugs 26:319-335.
62. Reddy DS (2013). Neuroendocrine aspects of catamenial epilepsy. Horm Behav 63:254-266.
63. Reiter SF, Veiby G, Daltveit AK, et al (2013). Psychiatric comorbidity and social aspects in pregnant women with epilepsy: the Norwegian Mother and Child Cohort Study. Epilepsy Behav 29:379-385.
64. Rugg-Gunn FJ, Sander JW (2012). Management of chronic epilepsy. BMJ 345:e4576.
65. Sabers A, Ohman I, Christensen J, et al (2003). Oral contraceptives reduce lamotrigine plasma levels. Neurology 61:570-571.
66. Sahoo S, Klein P (2005). Maternal complex partial seizure associated with fetal distress. Arch Neurol 62:1304-1305.
67. Santosh D, Kumar TS, Sarma PS, et al (2007). Women with onset of epilepsy prior to marriage: disclose or conceal? Epilepsia 48:1007-1010.
68. Savic I (2014). Sex differences in human epilepsy. Exp Neurol 259:38-43.
69. Shannon GD, Alberg C, Nacul L, et al (2014). Preconception healthcare and congenital disorders: systematic review of the effectiveness of preconception care programs in the prevention of congenital disorders. Matern Child Health J 18:1354-1379.
70. Svalheim S, Taubøll E, Bjørnenak T, et al (2003). Do women with epilepsy have increased frequency of menstrual disturbances? Seizure 12:529-533.
71. Taylor D, Paton C, Kapur S (2012). The Maudsley Prescribing Guidelines in Psychiatry, Oxleas NHS Foundation. 11th Edition. London, Wiley Blackwell.
72. Vajda FJ, O’Brien TJ, Lander CM, et al (2014). The teratogenicity of the newer antiepileptic drugs-an update. Acta Neurol Scand 130:234-238.
73. Vajda FJ, Hitchcock A, Graham J, et al (2006). Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 13:645-654.
74. Viale L, Allotey J, Cheong-See F, et al (2015). Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet 386:1845-1852.
75. Voinescu PE, Pennell PB (2015). Management of epilepsy during pregnancy. Expert Rev Neurother 15:1171-1187.
76. Zelená V, Kuba R, Soška V, et al (2011). Depression as a prominent cause of sexual dysfunction in women with epilepsy. Epilepsy Behav 20:539-544.
77. Zhou JQ, Zhou LM, Chen LJ, et al (2012). Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women. Seizure 21:729-733.